Spyre Therapeutics
Earnings Surprise
Analysts estimated SYRE earnings of $-0.79 per share this quarter (Q4). SYRE's actual earnings were $-0.70 per share.
SYRE EPS surprise of 11.43%Analysts estimated SYRE earnings of $-0.76 per share this quarter (Q3). SYRE's actual earnings were $-0.15 per share.
SYRE EPS surprise of 80.30%Analysts estimated SYRE earnings of $-0.77 per share this quarter (Q2). SYRE's actual earnings were $-0.49 per share.
SYRE EPS surprise of 36.26%Analysts estimated SYRE earnings of $-0.86 per share this quarter (Q1). SYRE's actual earnings were $-0.60 per share.
SYRE EPS surprise of 30.05%Analysts estimated SYRE earnings of $-1.01 per share this quarter (Q4). SYRE's actual earnings were $-0.81 per share.
SYRE EPS surprise of 20.11%Analysts estimated SYRE earnings of $-0.84 per share this quarter (Q3). SYRE's actual earnings were $-1.36 per share.
SYRE EPS surprise of -61.73%Analysts estimated SYRE earnings of $-0.97 per share this quarter (Q2). SYRE's actual earnings were $-0.86 per share.
SYRE EPS surprise of 11.25%Analysts estimated SYRE earnings of $-0.80 per share this quarter (Q4). SYRE's actual earnings were $-4.05 per share.
SYRE EPS surprise of 406.25%Analysts estimated SYRE earnings of $-0.86 per share this quarter (Q3). SYRE's actual earnings were $-9.34 per share.
SYRE EPS surprise of 983.65%